Is primary sclerosing cholangitis (PSC) or primary biliary cholangitis (PBC) associated with celiac disease?

PSC is Associated with Celiac Disease; PBC Has a Weaker Association

Primary sclerosing cholangitis (PSC) may rarely be associated with celiac disease as part of its spectrum of immune-mediated comorbidities, while primary biliary cholangitis (PBC) shows a threefold increased risk of coexistence with celiac disease compared to the general population.

PSC and Celiac Disease Association

The 2019 British Society of Gastroenterology guidelines explicitly state that PSC may rarely be associated with celiac disease among other immune-mediated diseases including thyroid disease, Sjögren's syndrome, type 1 diabetes mellitus, and systemic sclerosis 111. This association is uncommon but recognized in clinical practice.

Key Clinical Points for PSC:

• The association is rare but documented in guideline literature
• When present, celiac disease should be considered in PSC patients with severe steatorrhea or malabsorption symptoms 2
• The relationship appears immunologically mediated given PSC's autoimmune nature
• Celiac disease does not respond to PSC treatment and vice versa - each requires independent management 2

Screening Considerations:

While the association exists, routine screening of all PSC patients for celiac disease is not recommended based on current guidelines. However, investigate for celiac disease when PSC patients present with:

• Unexplained severe steatorrhea (>200 mmol/day fecal fat)
• Significant weight loss beyond what cholestasis explains
• Chronic diarrhea
• Malabsorption symptoms

PBC and Celiac Disease Association

For PBC, population-based data demonstrates a threefold increased prevalence of coexistence with celiac disease 3. A 2005 UK General Practice Research Database study found PBC prevalence of 0.17% in celiac disease patients versus 0.05% in controls (OR 3.63,95% CI: 1.46-9.04) 3.

Important Caveats:

• The association is weaker than some earlier reports suggested 3
• Despite the increased risk, routine screening of celiac disease patients for PBC is difficult to justify based on current evidence 3
• Current guidelines recommend screening PBC patients for celiac disease when clinically indicated 4

Clinical Algorithm

When to investigate for celiac disease in PSC/PBC patients:

1. Gastrointestinal symptoms present:

   • Chronic diarrhea, steatorrhea, weight loss
   • Check tissue transglutaminase IgA antibodies
   • Perform upper endoscopy with duodenal biopsies if positive

2. Unexplained anemia or nutritional deficiencies:

   • Iron deficiency, B12 deficiency, folate deficiency
   • Consider celiac serologies

3. Hematological abnormalities:

   • Unexplained cytopenias beyond what liver disease explains 5

When to investigate for PSC/PBC in celiac disease patients:

1. Elevated cholestatic enzymes (ALP, GGT):

   • Perform MRCP for PSC evaluation 6
   • Check antimitochondrial antibodies for PBC

2. Persistent abnormal liver tests despite gluten-free diet:

   • Full cholestatic workup indicated

Strength of Evidence

The guideline evidence (2019 BSG/UK-PSC guidelines) provides the strongest framework 111. The association is acknowledged but characterized as uncommon. Population-based research supports a real but modest association, particularly for PBC 3. Case reports and small series document the coexistence but are insufficient to mandate universal screening 4782.

Common Pitfall to Avoid:

Do not assume that treating one condition will improve the other. The diseases require independent management strategies - gluten-free diet for celiac disease and appropriate biliary-directed therapy for PSC/PBC 2. The coexistence reflects shared autoimmune susceptibility rather than causal relationship.